About Us
Part of the global pharmaceutical UBI Group, UBI Pharma consolidates the Group’s established values and builds a strong foundation of technology and production in the manufacture of pharmaceuticals, providing world-class pharmaceutical quality products. We develop innovative products such as non-monoclonal antibodies, novel small molecule drugs, and specialty injectables.
Board of Directors

Director
Jung-Kuang Yang
- Education:
- EMBA , Business Administration, National Taiwan Normal University
- Master/PhD candidate in Microbiology and Immunology, Shanghai Normal University
- Experience:
- Convener of the Chinese Medicine Industry Collaborative Research Team of the Expert Advisory Group on Chinese Medicine Researches and Knowledge Exchange, Ministry of Health and Welfare
- Chinese Medicine Industry Consultant, Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan
- Director, Shangzhi Asset Development Company
- Current Affiliation:
- Chairman, SCIENTIFIC PHARMACEUTICAL ELITE COMPANY
- Chairman, Science Park Energy Company
- Director, New Tatung Investment Consultants Ltd.
UBI Pharma Inc.
No.45, Guangfu N. Rd., Hukou Township, Hsinchu County 303036, Taiwan (R.O.C.)
- Tel:+886-3-5977676
- Fax:+886-3-5981173